0001104659-14-010722.txt : 20140214 0001104659-14-010722.hdr.sgml : 20140214 20140214172648 ACCESSION NUMBER: 0001104659-14-010722 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140214 DATE AS OF CHANGE: 20140214 EFFECTIVENESS DATE: 20140214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ContraVir Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001583771 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 462783806 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-212036 FILM NUMBER: 14619354 BUSINESS ADDRESS: STREET 1: 420 LEXINGTON AVENUE STREET 2: SUITE 2012 CITY: NEW YORK STATE: NY ZIP: 10170 BUSINESS PHONE: 212-297-0020 MAIL ADDRESS: STREET 1: 420 LEXINGTON AVENUE STREET 2: SUITE 2012 CITY: NEW YORK STATE: NY ZIP: 10170 D 1 primary_doc.xml X0707 D LIVE 0001583771 ContraVir Pharmaceuticals, Inc. 420 Lexington Avenue Suite 2012 New York NY NEW YORK 10170 212-297-0020 DELAWARE None None Corporation true 2013 Gary S. Jacob 420 Lexington Avenue Suite 2012 New York NY NEW YORK 10170 Executive Officer Director Bernard F. Denoyer 420 Lexington Avenue Suite 2012 New York NY NEW YORK 10170 Executive Officer Director John P. Brancaccio 420 Lexington Avenue Suite 2012 New York NY NEW YORK 10170 Director Christopher McGuigan 420 Lexington Avenue Suite 2012 New York NY NEW YORK 10170 Director Timothy Block 420 Lexington Avenue Suite 2012 New York NY NEW YORK 10170 Director Biotechnology No Revenues 06b false 2014-02-04 false true true false 25000 3225000 3225000 0 false 19 0 0 0 true In the ordinary course of business, the issuer may use some of the proceeds to pay salaries to its officers and directors. false ContraVir Pharmaceuticals, Inc. /s/ Gary S. Jacob Gary S. Jacob Chief Executive Officer 2014-02-14